Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "6957b1f01063d98b1e8f2f17", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Opipramol Dihydrochloride 100 mg", "description": "OPIRAPROL 100, featuring Opipramol Dihydrochloride 100 mg, stands out as a reliable medication from Steris Healthcare Pvt Ltd designed to address anxiety disorders and related somatic issues. This tricyclic compound offers targeted relief by modulating brain chemicals for better emotional balance. Patients often find it helps restore daily functionality without the heavier sedation of some alternatives.\n​\n\nProduct Overview\nOPIRAPROL 100 contains 100 mg of Opipramol Dihydrochloride per tablet, a dibenzazepine derivative primarily classified as an anxiolytic with antidepressant properties. Manufactured by Steris Healthcare Pvt Ltd, it targets generalized anxiety disorder (GAD) and somatoform disorders, where physical symptoms like unexplained pain or fatigue stem from psychological stress. Unlike typical antidepressants that focus solely on serotonin reuptake, Opipramol acts as a sigma-1 receptor agonist, influencing calcium signaling and neurotransmitter release for a calming effect.\n​\n\nThe formulation ensures steady absorption, making it suitable for adults needing moderate to higher dosing. Each pack typically includes 10 tablets, priced accessibly for ongoing therapy under medical supervision. Steris emphasizes quality with WHO-GMP certification, positioning OPIRAPROL 100 as a trusted option in India's mental health market.\n​\n\nHow It Works\nOpipramol Dihydrochloride in OPIRAPROL 100 primarily binds to sigma receptors in the brain, promoting translocation to cell membranes and enhancing neurotransmitter modulation, especially serotonin and dopamine. This biphasic action first reduces acute tension and insomnia, then stabilizes mood over time by downregulating sigma-2 sites during chronic use.\n​\n\nIt also exhibits mild antihistamine and anticholinergic effects, contributing to its sedative properties without strong reuptake inhibition like classic tricyclics. By calming overactive neural pathways, it alleviates the cycle of worry and physical unease, allowing clearer thinking and restful sleep. Clinical studies highlight its efficacy in somatoform cases, where patients fixate on bodily sensations amplified by anxiety.\n​\n\nKey Uses\nHealthcare providers prescribe OPIRAPROL 100 for several interconnected conditions rooted in anxiety.\n\nGeneralized anxiety disorder, easing excessive worry, restlessness, and irritability that disrupt work and relationships.\n​\n\nSomatoform disturbances target fatigue, pain, or gastrointestinal issues without clear organic cause.\n​\n\nMild depressive episodes with prominent anxiety, supporting mood without full antidepressant escalation.\n​\n\nAdjunctive therapy for sleep bruxism or insomnia linked to stress, based on emerging evidence.\n​\n\nIn practice, it suits patients in high-stress environments, like urban professionals in Jaipur facing daily pressures, helping them regain focus and productivity.\n​\n\nKey Benefits\nUsers of OPIRAPROL 100 report transformative effects that extend beyond symptom relief.\n\nRapid anxiety reduction promotes mental clarity, enabling better concentration and decision-making in daily tasks.\n​\n\nMood stabilization balances emotional swings, fostering stronger interpersonal connections and resilience.\n​\n\nEnhanced sleep quality combats insomnia, leading to refreshed mornings and sustained energy.\n​\n\nImproved daily functioning boosts productivity, which is vital for professionals balancing career and personal life.\n​\n\nLower sedation profile compared to benzodiazepines allows safe use during daytime hours.\n​\n\nLong-term, it enhances quality of life by breaking anxiety cycles, with many patients noting fewer somatic complaints after consistent use.\n​\n\nDosage Guidelines\nTake OPIRAPROL 100 as directed, typically 100 mg once or twice daily for adults, swallowed whole with water, with or without food. Start low to assess tolerance, adjusting up to 300 mg daily for severe cases under supervision.\n​\n\nFor children over 6, dosing follows 3 mg/kg body weight, but adult use predominates. Maintain consistent timing to stabilize blood levels, and taper gradually to avoid withdrawal. Missed doses should resume normally without doubling.\n\nPotential Side Effects\nMost side effects of OPIRAPROL 100 are mild and diminish with time, but monitoring remains essential.\n\nCommon ones (1-10%) include dry mouth, nasal congestion, fatigue, dizziness, and orthostatic hypotension, often resolving as the body adjusts.\n\nOccasional (0.1-1%) effects encompass constipation, weight gain, tremor, blurred vision, tachycardia, and mild liver enzyme elevation.\nRare issues (<0.1%) like allergic rashes, urinary retention, confusion, or leukopenia require immediate medical attention, especially in elderly patients or those with heart conditions.\n​\nPrecautions\nAvoid OPIRAPROL 100 in acute glaucoma, urinary retention, ileus, or uncontrolled epilepsy due to anticholinergic risks.\n​\nPregnant or lactating women need doctor approval, as safety data limits use. Steer clear of alcohol and CNS depressants to prevent amplified drowsiness.\n\nMonitor heart rhythm in bradycardia patients and liver function during prolonged therapy. Abrupt stops can trigger rebound anxiety.\nWhen to Consult a Doctor\nSeek prompt advice if side effects intensify, mood worsens paradoxically, or new symptoms like chest pain emerge. Regular check-ins ensure optimal dosing, particularly for those on interacting meds like MAOIs.\n​\nConclusion\nOPIRAPROL 100 with Opipramol Dihydrochloride 100 mg delivers effective, balanced relief for anxiety and somatic disorders, empowering users toward calmer, more productive lives. Backed by Steris Healthcare's commitment to quality, it bridges the gap between symptom management and holistic well-being when used responsibly. Always prioritize professional guidance to maximize benefits while minimizing risks.\n", "price": 154.0, "discountamount": 46.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2259, "imageuri": "https://productimages.withfloats.com/actual/6957b22c6b1ead52de1e2df4.png", "tileimageuri": "https://productimages.withfloats.com/tile/6957b22c6b1ead52de1e2df4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-02T11:54:24.869Z", "updatedon": "2026-03-13T07:53:58.661Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/opipramol-dihydrochloride-100-mg/2259", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OPIRAPROL 100", "category": "NEUROLOGYRANGE", "tags": [ "opipramol dihydrochloride.", "opipramol dihydrochloride tablets uses.", "opipramol dihydrochloride tablets uses in hindi.", "opipramol dihydrochloride tablets.", "opipramol dihydrochloride uses.", "opipramol dihydrochloride side effects", "opipramol dihydrochloride tablet.", "what is opipramol dihydrochloride.", "side effects of opipramol dihydrochloride.", "opipramol dihydrochloride dosage.", "opipramol dihydrochloride tablet for anxiety disorder", "medicine for generalized anxiety disorder treatment", "tablet for anxiety and stress management", "medication for nervous tension and anxiety", "how opipramol dihydrochloride works for anxiety", "opipramol vs amitriptyline for anxiety", "medicines for stress and anxiety relief", "opipramol dihydrochloride tablets supplier india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694919f0de5d3e57a93413a8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "elagolix 150mg tablet", "description": "Eligolux 150 delivers 150mg of elagolix per tablet, formulated as an oral, once-daily option in convenient packs for ongoing therapy. As a non-peptide GnRH receptor antagonist, it selectively suppresses pituitary gonadotropins, reducing ovarian estrogen production without the flare effect of agonists. Ideal for patients with milder symptoms or those prioritizing bone health, this dose minimizes hypoestrogenic risks while targeting endometriotic pain.\n\nTake Eligolux 150 whole with water, with or without food, preferably at the same time daily. Storage requires a cool, dry environment below 30°C, away from children and moisture. Steris Healthcare ensures GMP-compliant manufacturing, making it accessible across India for endometriosis care.\n\nPrimary Uses and Indications\nEligolux 150 primarily treats moderate endometriosis-associated pain, including dysmenorrhea, chronic pelvic discomfort, and dyspareunia. Endometriosis impacts 10% of reproductive-age women, causing ectopic endometrial growth that triggers inflammation and scarring; elagolix 150mg curbs estrogen-driven progression.\n​\nPrescribed when NSAIDs or combined pills prove inadequate, it excels in non-severe cases, allowing prolonged use. Emerging evidence supports its role in heavy menstrual bleeding from fibroids, though primary approval focuses on pain relief. Start therapy within the first week of menses for optimal synchronization.\n​\nMechanism of Action\nElagolix in Eligolux 150 competitively binds GnRH receptors, dose-dependently inhibiting LH/FSH release. This lowers estradiol by 40-60%—less aggressive than 200mg—halting endometrial tissue proliferation outside the uterus. Peak levels hit in 1 hour, with a 4-6 hour half-life supporting steady-state suppression on QD dosing.\n​\nUnlike agonists, no initial hormone surge occurs, preventing worsened pain. Partial estrogen reduction preserves some bone-protective effects, differentiating it from deeper suppression therapies.\n\nKey Benefits\nEligolux 150 shines in clinical responsiveness: phase 3 trials showed 32% dysmenorrhea resolution versus 20% placebo at 6 months, with 50% pain score drops. Quality-of-life gains include better work attendance, sleep, and relationships, per EQ-5D assessments.\n​\nExtended 24-month approval suits long-term control, with amenorrhea in 40-50% of users reducing bleeding volume by 70%. Oral ease beats injectables, enhancing adherence at 85% in studies. Lower BMD impact (0.5-1% loss/year) allows safer continuation versus higher doses.\n\nBenefit\tTrial Data\tPatient Impact\nPain Reduction\t32-50% dysmenorrhea-free \n​\tDaily activity restoration\nBleeding Control\t70% volume drop \n​\tAnemia prevention\nLong-Term Use:\tUp to 24 months \n​\tSustained relief\nQoL Improvement\tEQ-5D gains \n​\tEmotional well-being\nPotential Side Effects\nVasomotor symptoms dominate: hot flashes (20-30%), headaches (17%), and night sweats (10-15%) emerge early but fade. Nausea (8%), insomnia (7%), and mild depression (5%) affect minorities, with a 70% event rate mostly grade 1.\n​\nBMD decline averages -0.9% at the spine after 12 months, monitored via DEXA. Discontinuation hovers at 5-8%.\n\nSide Effect\tIncidence\tMitigation\nHot Flashes\t20-30% \n​\tVentilation, timing\nHeadache\t17% \n​\tAnalgesics\nBMD Loss\t0.9% \n​\tSupplements, scans\nMood Shifts\t5% \n​\tMonitoring\nSerious Risks and Management\nSuicidality (0.1-0.5%) demands baseline psych screening; halt if worsening. Liver enzymes rise in 1%, requiring LFTs at 3/6 months. Rare anaphylaxis or thromboembolism prompts immediate cessation. Avoid in osteoporosis or smokers >35.\n​\n\nDosage Guidelines\n150 mg once daily for up to 24 months in normal/mild liver function; limit to 6 months in moderate impairment (Child-Pugh B). No titration needed; miss a dose? Resume the next day, no doubling. Pair with 1 g calcium/800 IU vitamin D daily.\n​\n\nPrecautions and Contraindications\nPregnancy category X: mandates non-hormonal birth control during and 1 week post-therapy. Screen hepatic/renal function; avoid severe cases. CYP3A interactions (e.g., rifampin reduces efficacy) need dose review. Breastfeeding is contraindicated.\n​\nClinical Evidence and Efficacy\nElaris trials (n=1,689) confirmed superiority: co-primary endpoints met with 75% responder rates for pain. 12-month extensions showed persistent efficacy and low rebound. Versus 200mg, 150mg balances tolerability for moderate pain.\n​\nConclusion\nEligolux 150 empowers women with moderate endometriosis pain through precise, extended hormonal modulation and proven outcomes. Regular physician oversight maximizes safety and efficacy.\n", "price": 700.0, "discountamount": 210.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2252, "imageuri": "https://productimages.withfloats.com/actual/694a2af01e4092f757d90bb5.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2af01e4092f757d90bb5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T10:14:08.773Z", "updatedon": "2026-03-26T05:59:45.544Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-150mg-tablet/2252", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 150", "category": "GYANECOLOGYRANGE", "tags": [ "elagolix 150mg tablet", "prioritizing bone health.", "endometriotic pain.", "endometrial tissue proliferation outside the uterus.", "Eligolux 150 empowers women with moderate endometriosis pain through precise.", "hormonal modulation and proven outcomes.", "gonadotropins.", "endometriotic pain." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948f4ee5837f90c86a7e578", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Elagolix 200mg ", "description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n​\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n​\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n​\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n​\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n​\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n​\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n​\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n​\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n​\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n​\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n​\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n​\tDEXA scans, supplements\nMood Changes\tLess common \n​\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n​\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near the next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n​\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n​\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n​\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n​\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n", "price": 1000.0, "discountamount": 300.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2251, "imageuri": "https://productimages.withfloats.com/actual/694a2b9f403179ac7e958ef6.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2b9f403179ac7e958ef6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T07:36:14.316Z", "updatedon": "2026-03-26T06:00:31.59Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-200mg-/2251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 200", "category": "GYANECOLOGYRANGE", "tags": [ "Elagolix Tablets 200mg", "Elagolix acts as a potent gonadotropin-releasing hormone.", "nonmenstrual pelvic pain.", "adhesions, and scarring", "preserving bone health better than monotherapy.", "avoiding invasive laparoscopies and reclaiming normalcy.", "pituitary gland to rapidly reduce estrogen and progesterone.", "tab elagolix 200mg", "elagolix 200mg.", "elagolix.", "elagolix 200.", "elagolix tablets", "elagolix tablets uses.", "elagolix 200 mg price.", "elagolix mechanism of action.", "elagolix 200 mg uses.", "tab elagolixtab elagolix." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662e3b87247ae19c482b97c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Enzalutamide 40mg", "description": "Enzalutamide 40 mg capsules represent a breakthrough in targeted therapy for advanced prostate cancer, particularly in metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC). This second-generation androgen receptor inhibitor works by disrupting multiple steps in the androgen signaling pathway, offering patients a chance to slow disease progression, reduce tumor burden, and extend survival even after other treatments fail. Administered as a once-daily oral capsule, enzalutamide 40 mg provides four capsules per day (total 160 mg), making it convenient for long-term use in clinical settings where hormone therapy alone proves insufficient.​\n\nPatients often turn to enzalutamide when facing rising PSA levels despite androgen deprivation therapy (ADT), experiencing bone pain, or dealing with cancer spread to lymph nodes or distant sites. Its high affinity for androgen receptors—5-8 times stronger than first-generation antiandrogens like bicalutamide—ensures potent blockade without agonist activity, translating to real-world benefits like delayed chemotherapy needs and improved quality of life during treatment.​\n\nProduct Use and Indications\nEnzalutamide 40 mg primarily treats metastatic castration-resistant prostate cancer (mCRPC) in patients previously treated with docetaxel or progressing despite ADT. The FDA and EMA approvals extend to non-metastatic CRPC (nmCRPC) with high-risk biochemical recurrence and metastatic castration-sensitive prostate cancer (mCSPC) alongside ADT, based on landmark trials like AFFIRM, PREVAIL, PROSPER, and ARCHES.​\n\nKey uses include:\n\nSlowing tumor growth in hormone-refractory stages by inhibiting androgen-driven proliferation.\n\nReducing skeletal-related events like fractures or spinal cord compression in bone metastases.\n\nDelaying progression to chemotherapy in pre-chemotherapy mCRPC, with PREVAIL showing 17-month median radiographic progression-free survival (rPFS) versus 4 months for placebo.​\n\nIn mCSPC, ARCHES trial data demonstrated 61% risk reduction in progression or death when combined with ADT. Clinicians monitor PSA response (≥50% decline in 70-80% of patients) and imaging every 3 months to assess efficacy.​\n\nMechanism of Action\nEnzalutamide 40 mg exerts a threefold blockade on androgen receptor (AR) signaling: it competitively inhibits androgen binding to AR (with affinity rivaling dihydrotestosterone), prevents nuclear translocation of the ligand-receptor complex, and disrupts DNA binding and coactivator recruitment at androgen response elements. This comprehensive inhibition downregulates oncogenes like TMPRSS2-ERG fusion genes common in prostate cancer, inducing apoptosis and halting cell proliferation without lowering systemic testosterone levels.​\n\nUnlike earlier antiandrogens, enzalutamide avoids partial agonist effects, ensuring pure antagonism even in AR-overexpressing tumors. Its active metabolite, N-desmethyl enzalutamide (via CYP2C8), contributes 30% to activity, with steady-state levels achieved in 4 weeks.​\n\nKey Benefits\nExtended Progression-Free Survival: In PREVAIL (pre-chemo mCRPC), median overall survival reached 32.4 months versus 30.2 for placebo; PROSPER (nmCRPC) delayed metastasis by 22 months.​\n\nPSA Response and Tumor Shrinkage: 78% PSA90 response rate; radiographic responses in 29% with measurable disease.​\n\nQuality of Life Preservation: Delays pain progression (hazard ratio 0.40) and chemotherapy (by 17 months), maintaining daily function.​\n\nBone Protection: Reduces fractures by 30% in high-risk patients via AR inhibition in osteoblasts.​\n\nCombination Synergy: Enhances ADT efficacy in mCSPC, cutting death risk by 33% per ARCHES.​\n\nThese benefits position enzalutamide 40 mg as a cornerstone in modern prostate cancer protocols, especially for fit patients tolerating oral therapy.​\n\nSide Effects\nEnzalutamide 40 mg carries a manageable profile, with most effects dose-related and reversible upon discontinuation.\n\nCommon Side Effects\nFatigue/Asthenia (34-50%): Often mild, peaking in first months; rest and nutrition help.\n\nArthralgia/Myalgia (14-21%): Joint/muscle pain managed with NSAIDs.\n\nHot Flashes (20%): Androgen blockade mimic; hydration aids.\n\nHeadache/Dizziness (12-19%): Transient; avoid driving if severe.\n\nHypertension (6-13%): Monitor BP monthly; antihypertensives as needed.\n\nGI Issues (diarrhea 12%, nausea 11%): Antiemetics support compliance.​\n\nSerious Side Effects\nSeizures (0.9%): Highest risk in epileptics or brain mets; EEG baseline, avoid triggers.\n\nPosterior Reversible Encephalopathy (PRES): Rare (<0.1%); headache, confusion—MRI confirms.\n\nFalls/Fractures (15% increased risk): Due to weakness/falls; DEXA scans recommended.\n\nCardiac Events (2-5%): MI/arrhythmias; ECG monitoring in CVD history.\n\nHepatic Injury (1%): ALT/AST elevation; monthly labs first 3 months.​\n\nDiscontinuation occurs in 8-10%; supportive care mitigates most.​\n\nDosage and Administration\nStandard dose: 160 mg (four 40 mg capsules) once daily, with or without food. Swallow intact; no crushing. Adjust for CYP2A4 inducers (e.g., rifampin—increase to 240 mg) or strong inhibitors (reduce to 80 mg). Continue until progression/toxicity; no dose interruptions beyond 28 days without reassessment.​\n\nPrecautions and Monitoring\nContraindicated in pregnancy (teratogenic; absolute contraception for men/ partners). Screen for seizure history; CYP2C8/3A4 interactions (e.g., ketoconazole). Baseline LFTs, PSA, testosterone; imaging q8-12 weeks. Elderly (>75) monitor falls.​\nConclusion\nEnzalutamide 40 mg stands as a transformative therapy, empowering prostate cancer patients with prolonged control over aggressive disease through precise AR inhibition. Balancing robust efficacy—evidenced by landmark trials delaying metastasis and death—with proactive side effect management, it enhances survival and daily living. Patients achieve meaningful milestones, from family events to travel, underscoring its role in personalized oncology. Consult oncologists for integration into care plans, ensuring optimal outcomes in this challenging journey.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\n\n\n\n\n\n\n\n\n", "price": 10781.0, "discountamount": 3235.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "Email", "doctor", "product", "fatigue", "WhatsApp", "treatment", "schedules", "ENZULAMIDE", "monitoring", "hot flashes", "information", "sterisonline", "hypertension", "sterispharma", "prostate cancer", "Enzalutamide 40mg", "prescribed dosages", "androgen receptors", "cancer cell growth", "Common side effects", "comprehensive guidance" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1527, "imageuri": "https://productimages.withfloats.com/actual/667d2a356c582d228f45a098.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2a356c582d228f45a098.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:40:56.587Z", "updatedon": "2026-03-16T08:18:18.117Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//enzalutamide-40mg/1527", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ENZULAMIDE 40", "category": "Oncology", "tags": [ "enzalutamide 40 mg side effects", "enzalutamide 40 mg brands in india", "enzalutamide 40 mg uses in hindi", "enzalutamide 40 mg dosage", "advanced prostate cancer", "prostate cancer", "metastatic castration-resistant prostate cancer", "enzalutamide 40mg tablets", "enzalutamide 40 mg capsule", "enzalutamide 40mg uses", "enzalutamide 40mg dosage", "enzalutamide 40mg price in india", "enzalutamide 40mg composition", "enzalutamide 40mg working mechanism", "enzalutamide 40mg side effects", "enzalutamide 40mg benefits", "enzalutamide 40mg drug information", "enzalutamide 40mg therapy details", "enzalutamide 40mg oral capsule", "enzalutamide 40mg treatment option", "enzalutamide 40mg pharmaceutical uses", "enzalutamide 40mg branded tablets", "enzalutamide 40mg generic medicine", "enzalutamide 40mg manufacturer in india", "what is enzalutamide 40mg used for", "how enzalutamide 40mg works", "is enzalutamide 40mg safe", "enzalutamide 40mg tablet information", "enzalutamide 40mg dosage guidelines" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6ae5ddc42400c0ad258fb750", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mycophenolic Acid Delayed-Release Tablets USP 360 mg", "description": "MYCOFORTIC S 360 is a pharmaceutical formulation containing Mycophenolic Acid Delayed-Release Tablets USP 360 mg. Mycophenolic Acid belongs to a class of medicines known as immunosuppressants. It is used to help prevent organ rejection in patients who have undergone kidney transplantation, as part of a combination immunosuppressive treatment regimen prescribed by a qualified healthcare professional.\n\nOrgan transplantation is an important medical procedure that helps patients with end-stage organ disease improve their quality of life. However, the body's immune system may recognize a transplanted organ as foreign and attempt to attack it. This immune response can lead to organ rejection.\n\nMYCOFORTIC S 360 contains Mycophenolic Acid, an active pharmaceutical ingredient that helps suppress certain immune responses. It works by inhibiting the proliferation of lymphocytes, which are important cells involved in the body's immune response.\n\nWith its delayed-release tablet formulation, MYCOFORTIC S 360 is designed to deliver Mycophenolic Acid through a specialized release mechanism. It is intended for use under strict medical supervision as part of an individualized post-transplant treatment plan.", "price": 816.0, "discountamount": 245.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2510, "imageuri": "https://productimages.withfloats.com/actual/6ae5ddc7bc27d43423ad0aec.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ae5ddc7bc27d43423ad0aec.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-31T12:23:32.198Z", "updatedon": "2026-10-31T12:23:32.198Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mycophenolic-acid-delayed-release-tablets-usp-360-mg/2510", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOFORTIC S 360", "category": null, "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ae5dbe40b7c3d020d7c3b40", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Combipack Of Vonoprazan Tablets 20 mg,Clarithromycin Tablets IP 500 mg & Amoxycillin Capsules IP 500", "description": "VONOSTRUM HP KIT is a pharmaceutical combination pack containing Vonoprazan Tablets 20 mg, Clarithromycin Tablets IP 500 mg, and Amoxicillin Capsules IP 500 mg. This combination is designed for use as part of a physician-prescribed treatment regimen for Helicobacter pylori (H. pylori) infection, a type of bacterial infection associated with the stomach and gastrointestinal tract.\n\nVONOSTRUM HP KIT combines an acid-suppressing agent with two antibiotics to support H. pylori eradication therapy. The combination works through different mechanisms: Vonoprazan helps reduce stomach acid production, while Clarithromycin and Amoxicillin act against susceptible bacterial infections.\n\nWith its convenient combipack formulation, VONOSTRUM HP KIT brings three complementary medicines together in one treatment pack, helping simplify the prescribed treatment schedule.", "price": 149.0, "discountamount": 40.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2509, "imageuri": "https://productimages.withfloats.com/actual/6ae5dbe783548115dde7d54d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ae5dbe783548115dde7d54d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-31T12:15:32.163Z", "updatedon": "2026-10-31T12:15:32.163Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//combipack-of-vonoprazan-tablets-20-mg-clarithromycin-tablets-ip-500-mg-amoxycillin-capsules-ip-500/2509", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VONOSTRUM HP KIT", "category": null, "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ae5d88f695d7aeb49179417", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Triamcinolone Acetonide Injection 40 mg IP", "description": "TRISULPHON CORT is a pharmaceutical formulation containing Triamcinolone Acetonide Injection 40 mg IP, belonging to the corticosteroid class of medicines. Triamcinolone Acetonide is a synthetic corticosteroid widely recognized for its anti-inflammatory and immunosuppressive properties. It is used under appropriate medical supervision to help manage various inflammatory, allergic, and immune-related conditions, depending on the prescribed route of administration and approved product indications.\n\nCorticosteroids play an important role in modern medical treatment because of their ability to regulate inflammatory responses within the body. By reducing the release and activity of certain substances responsible for inflammation, Triamcinolone Acetonide helps healthcare professionals manage conditions associated with swelling, redness, irritation, and inflammatory discomfort.\n\nTRISULPHON CORT Injection is intended for use under the guidance of qualified healthcare professionals. Its administration, dosage, and treatment duration should always be determined by a registered medical practitioner according to the patient's medical condition and individual requirements.", "price": 165.0, "discountamount": 45.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2508, "imageuri": "https://productimages.withfloats.com/actual/6ae5d892fe30914231ab3937.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ae5d892fe30914231ab3937.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-31T12:01:19.584Z", "updatedon": "2026-10-31T12:01:19.584Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//triamcinolone-acetonide-injection-40-mg-ip/2508", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRISULPHON CORT", "category": null, "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ae5d554245214b8e9f4b2fe", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Combipack of Amoxicillin Tablets USP,Omeprazole Capsules IP & Tinidazole Tablets IP", "description": "PANTOSTRUM OME HP KIT is a three-in-one combipack of Amoxicillin 750 mg Tablets USP, Omeprazole 20 mg Capsules IP, and Tinidazole 500 mg Tablets IP. Each component acts differently, and a doctor may prescribe them together for certain stomach and gut conditions. The kit is meant to be used only on a qualified physician’s advice.\n\nWhat Is Inside the Kit\nComponent\tDrug class\tPrimary role\nAmoxicillin 750 mg Tablets USP\tPenicillin-type antibiotic\tActs against susceptible bacteria\nOmeprazole 20 mg Capsules IP\tProton Pump Inhibitor (PPI)\tLowers stomach acid\nTinidazole 500 mg Tablets IP\tNitroimidazole antimicrobial\tActs against certain anaerobic bacteria and protozoa\nAmoxicillin 750 mg\n\nAmoxicillin is a broad-spectrum antibiotic from the penicillin family. It blocks bacteria from building their cell walls, so the bacteria cannot survive. Within a multi-drug regimen, it targets susceptible bacteria linked to gastrointestinal infection. Whether to use it is the prescriber’s decision, guided by antibiotic stewardship guidelines.\n\nOmeprazole 20 mg\n\nOmeprazole is a PPI. It switches off the proton pumps in the stomach lining that produce acid, so the stomach becomes less acidic. It is widely used for acid-related conditions such as GERD and peptic ulcer disease. In a combination regimen, lower acid levels can support the overall treatment.\n\nTinidazole 500 mg\n\nTinidazole belongs to the nitroimidazole group. It damages the DNA of susceptible anaerobic bacteria and protozoa, which stops them from multiplying. It is prescribed for specific infections under medical supervision, and in this kit it adds a further antimicrobial effect where clinically suitable.", "price": 125.0, "discountamount": 37.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2507, "imageuri": "https://productimages.withfloats.com/actual/6ae5d5567b5622859fa6fbd0.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ae5d5567b5622859fa6fbd0.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-31T11:47:32.806Z", "updatedon": "2026-10-31T11:47:32.806Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//combipack-of-amoxicillin-tablets-usp-omeprazole-capsules-ip-tinidazole-tablets-ip/2507", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PANTOSTRUM OME HP KIT", "category": null, "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ae2fef4545d3197abde920c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Faropenem Disperible Tablets 100 mg", "description": "Faropinom 100 DT is a prescription-only antibiotic that provides 100 mg of Faropenem in a dispersible tablet. Faropenem is a penem-type beta-lactam, and doctors use it to treat bacterial infections only when the causative organism is likely to respond to it.\n\nAbout Faropinom 100 DT\n\nThe active ingredient, Faropenem, stops bacteria from building a proper cell wall. The weakened bacteria cannot survive, which helps the body clear a susceptible infection.\n\nThe tablet is meant to be mixed into water before it is taken. This can suit patients who find whole tablets hard to swallow. It should be used strictly as prescribed and according to the leaflet in the pack.\n\nProduct Snapshot\nFeature\tDetails\nBrand\tFaropinom 100 DT\nActive ingredient\tFaropenem 100 mg\nClass\tPenem beta-lactam antibiotic\nForm\tDispersible tablet\nMode of action\tBlocks bacterial cell-wall synthesis\nAvailability\tPrescription-only; subject to Indian regulations\nPurpose\tTreating susceptible bacterial infections on a doctor’s advice\nWhere Faropenem May Be Used\n\nWhether Faropenem is chosen depends on the patient’s condition, the bacteria involved (suspected or confirmed), prevailing treatment guidelines and the approved product information. Infections for which it may be considered include:\n\nRespiratory infections: bacterial infections of the airways or lungs, where the organism is sensitive to Faropenem.\nUrinary infections: bacterial infections of the bladder or wider urinary tract, at a clinician’s discretion.\nEar, nose and throat infections: certain bacterial infections of the ears, throat or sinuses, after examination.\nSkin and soft-tissue infections: selected bacterial skin infections, depending on severity and the organisms responsible.\nOther infections: any further use must follow approved indications, laboratory susceptibility and the treating doctor’s judgement.\n\nPlease note: This antibiotic does not suit every infection. It should never be assumed appropriate for all chest, urinary, skin or genital conditions. Only a qualified healthcare professional can decide whether it is right for a particular patient.\n\nNotable Characteristics\n\n1. Bactericidal action. Faropenem attacks susceptible bacteria by interfering with the machinery that builds their cell walls. How well it works depends on the species and its susceptibility.\n\n2. Activity against some enzyme-producing bacteria. Certain bacteria make beta-lactamase enzymes that disable some beta-lactam antibiotics. Faropenem can work against some of these organisms, but results differ by bacterium and resistance mechanism. It is not a universal answer to resistant infections.\n\n3. Easy-to-prepare format. The tablet is dispersed in water following the pack instructions, which helps those who struggle with swallowing conventional tablets.\n\n4. Focused treatment. Matched to the right infection, it targets the responsible bacteria. Choosing the right antibiotic improves outcomes and limits needless antibiotic exposure.\n\n5. Oral route. When oral therapy is clinically suitable, treatment can proceed without injections. The prescriber decides the route based on the patient’s condition.\n\nHow Faropenem Works\n\nFaropenem attaches to penicillin-binding proteins, which bacteria rely on to assemble and maintain their cell walls. With these proteins blocked, the wall cannot form properly, the bacterial structure weakens and the cell dies. This makes Faropenem bactericidal against susceptible organisms. It does not act on viruses and cannot treat every bacterial infection.\n\nDosing and Administration\n\nThe dose is set by the doctor after considering age, body weight (where relevant), the type and seriousness of the infection, and kidney function.\n\nDose: use only the strength and quantity prescribed.\nFrequency: follow the daily schedule given to you; do not alter it yourself.\nDuration: finish the prescribed course without lengthening or shortening it unless your doctor says so.\nPreparation: disperse the tablet as directed in the leaflet or by your pharmacist.\nMissed dose: check the leaflet or ask a pharmacist. Never double up to make up for a forgotten dose.\n\nNo single dosing plan fits all patients, so a general range should never replace a personal prescription.\n\nPossible Side Effects\n\nAs with other antibiotics, reactions can occur, and they vary from person to person.\n\nMilder effects may include:\n\nNausea or stomach upset\nAbdominal discomfort\nLoose stools or diarrhoea\nRash or itching\nHeadache or dizziness\n\nSpeak to a healthcare professional if these continue, become bothersome or get worse.\n\nGet medical help promptly for:\n\nSerious allergy: swelling of the face, lips, tongue or throat, or trouble breathing is an emergency.\nSevere diarrhoea: persistent, watery or bloody stools may signal a serious antibiotic-related complication.\nSevere skin reaction: widespread rash, blisters or peeling skin needs urgent assessment.\nLiver concerns: yellow skin or eyes, or dark urine, should be checked quickly.\n\nThis list is not exhaustive. Refer to the product information and your doctor for advice specific to you.\n\nPrecautions and Warnings\nAllergies: tell your doctor about any past allergy to Faropenem, penicillins, cephalosporins or other beta-lactams.\nKidney health: report any kidney disease or reduced function, as it can affect suitability and dosing.\nPregnancy and breastfeeding: consult your doctor first if you are pregnant, planning pregnancy or nursing. Use only after a personal benefit–risk assessment.\nOther medicines: share a full list of prescription drugs, over-the-counter products and supplements so interactions can be checked.\nAntibiotic resistance: take Faropenem only for a suitable bacterial infection. Misuse and incorrect dosing fuel resistance.\nMedical history: discuss existing conditions and earlier drug reactions before starting.\nWho Is It For?\n\nFaropinom 100 DT may be considered for patients who need an antibiotic for a susceptible bacterial infection and for whom this dispersible form is suitable. The prescriber decides based on examination, the likely or confirmed organism, individual risk factors and current guidance. It should not be self-started for fever, cough or sore throat without first establishing that an antibiotic is needed.\n\nBuying Faropinom 100 DT in India\n\nBefore purchasing, confirm the brand, strength, manufacturer and the legitimacy of the seller. For safety:\n\nGet a prescription from a registered medical practitioner.\nBuy from a licensed pharmacy or a duly authorised online pharmacy.\nInspect the name, strength, batch number, expiry date and pack condition.\nStore it as the packaging directs.\nAsk the pharmacist if anything is unclear.\n\nPrice and availability: these differ by manufacturer, pack size, pharmacy and location. Confirm current details with a licensed seller rather than an unverified figure.\n\nFrequently Asked Questions\n\n1. What is Faropinom 100 DT prescribed for?\nIt contains Faropenem 100 mg and is used for certain bacterial infections when the organism is susceptible and the medicine is clinically suitable.\n\n2. Is it an antibiotic?\nYes. Faropenem is a penem-class beta-lactam that disrupts bacterial cell-wall formation.\n\n3. What is the active ingredient?\nFaropenem 100 mg. Check the pack for full composition details.\n\n4. Will it cure a common cold?\nNo. Colds are viral, and antibiotics do not act on viruses.\n\n5. How do I take it?\nExactly as prescribed. Prepare the dispersible tablet in water as described in the leaflet or by your pharmacist.\n\n6. What is the right dose?\nIt depends on the infection, your age, kidney function and other individual factors. Follow your doctor’s prescription.\n\n7. How long is the course?\nThe duration depends on the infection and your response. Complete the course unless your doctor changes it.\n\n8. What side effects can occur?\nStomach upset, nausea, diarrhoea, headache and skin reactions are possible. Seek advice if they persist or become severe.\n\n9. Can it cause diarrhoea?\nYes, as antibiotics can. Contact a healthcare professional quickly if it is severe, long-lasting or bloody.\n\n10. Can I stop once I feel better?\nDo not stop or alter treatment on your own. Talk to your doctor about side effects or if you think treatment is no longer needed.\n\n11. Is it safe in pregnancy?\nA doctor must assess this individually. Do not use it in pregnancy without medical advice.\n\n12. Can I use it while breastfeeding?\nAsk your doctor first. The decision rests on available safety data and your circumstances.\n\n13. Can people with kidney problems take it?\nThey should tell their doctor beforehand, who will decide on suitability and any adjustment.\n\n14. Is Faropenem a penicillin?\nNo, it is a penem. Both are beta-lactams, so discuss any antibiotic allergy history with your prescriber.\n\n15. Is alcohol allowed during treatment?\nAsk your doctor or pharmacist, especially if you have other conditions or take other medicines. Avoid alcohol if it worsens symptoms.\n\n16. What if I miss a dose?\nConsult the leaflet or your pharmacist. Do not take a double dose unless a professional tells you to.\n\n17. Does it work on resistant bacteria?\nIt may act on certain bacteria that resist some other antibiotics, but this depends on the organism and resistance mechanism. Medical assessment is essential.\n\n18. Can it be used for any infection?\nNo. It is for suitable bacterial infections only, chosen through clinical assessment and, where needed, lab testing.\n\n19. What does it cost in India?\nConfirm the current price with a licensed pharmacy, as it varies by pack size, maker and location.\n\n20. Where can I buy it?\nEnquire at a licensed local or authorised online pharmacy. A valid prescription may be required under applicable rules.\n\nConclusion\n\nFaropinom 100 DT is a dispersible Faropenem 100 mg antibiotic for selected bacterial infections, to be used under a qualified healthcare professional’s guidance. It works by disrupting bacterial cell-wall formation, and the dispersible form offers an alternative for patients who find standard tablets difficult.\n\nResponsible use depends on accurate diagnosis, the right antibiotic choice, sticking to the prescribed regimen and watching for side effects. Always consult a healthcare professional before starting, stopping or changing antibiotic treatment.", "price": 590.0, "discountamount": 177.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2506, "imageuri": "https://productimages.withfloats.com/actual/6ae2fef754689b1ff0217bf5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ae2fef754689b1ff0217bf5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-29T08:08:20.798Z", "updatedon": "2026-10-29T08:08:20.798Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//faropenem-disperible-tablets-100-mg/2506", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Faropinom 100 DT", "category": null, "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
competitively priced?

Still searching for
competitively priced?

Chat with us